Literature DB >> 23861459

Unusual case of solitary functioning bone metastasis from a "parathyroid adenoma": imagiologic diagnosis and treatment with percutaneous vertebroplasty--case report and literature review.

Zhong-ling Qiu1, Chun-gen Wu, Rui-sen Zhu, Yan-li Xue, Quan-yong Luo.   

Abstract

BACKGROUND: Parathyroid carcinoma is a rare endocrine malignancy that accounts for a small percentage of patients with primary hyperparathyroidism. Here, an unusual patient with parathyroid carcinoma misdiagnosed as a parathyroid adenoma was reported. A solitary L4 vertebral metastasis, which was localized by technetium-99m-labelled methoxyisobutyl isonitrile ((99m)Tc-MIBI) single photon emission computed tomography (SPECT)/computed tomography (CT) fusing images, was successfully treated with percutaneous vertebroplasty (PVP) for the first time. PATIENT AND METHODS: A 53-year-old man with primary hyperparathyroidism and a palpable mass in the right neck was referred. A right unilateral parathyroidectomy was performed. A pathological diagnosis of parathyroid adenoma was made; however, hyperparathyroidism persisted with a serum calcium of 4.51 mmol/L and a PTH of 3235 pg/mL. Early and delayed images of the (99m)Tc-MIBI whole-body scan revealed abnormal (99m)Tc-uptake in the lower abdomen. The delayed (99m)Tc-MIBI SPECT/CT fusion images found that the lower abnormal (99m)Tc-MIBI uptake was located in the area of osteolytic destruction of the L4 vertebra. A bone metastasis from parathyroid carcinoma was diagnosed based on histopathological evaluation and immunohistochemical staining. PVP was performed to treat the osteolytic destruction of the L4 vertebra. The PTH level decreased to normal within 1 week after PVP.
CONCLUSION: (99m)Tc-MIBI SPECT/CT scan may be a useful and suitable method by which to localize functioning distant metastases from the parathyroid cancer when serum PTH and calcium levels remain greatly elevated after parathyroidectomy. PVP may be an effective procedure in eliminating cancer cells, reducing serum PTH levels, preventing bone fractures, and improving the quality of life of patients.

Entities:  

Mesh:

Year:  2013        PMID: 23861459     DOI: 10.1210/jc.2013-2014

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Incidentalomas during imaging for primary hyperparathyroidism--incidence and clinical outcomes.

Authors:  P Prasad; C Clout; E Lorenz; B J Harrison; S P Balasubramanian
Journal:  World J Surg Oncol       Date:  2015-09-17       Impact factor: 2.754

2.  Primary hyperparathyroidism-jaw tumor syndrome: a confusing and forgotten diagnosis.

Authors:  Doina Piciu; Andra Piciu; Elena Barbus; Claudiu Pestean; Maria Iulia Larg; Bogdan Fetica
Journal:  Clujul Med       Date:  2016-10-20

3.  Parathyroid carcinoma with sarcomatoid differentiation: a case report and literature review.

Authors:  Liang Hu; Xiaojun Xie
Journal:  Diagn Pathol       Date:  2020-12-14       Impact factor: 2.644

4.  Case Report: Abdominal Lymph Node Metastases of Parathyroid Carcinoma: Diagnostic Workup, Molecular Diagnosis, and Clinical Management.

Authors:  Christina Lenschow; Carmina Teresa Fuss; Stefan Kircher; Andreas Buck; Ralph Kickuth; Joachim Reibetanz; Armin Wiegering; Albrecht Stenzinger; Daniel Hübschmann; Christoph Thomas Germer; Martin Fassnacht; Stefan Fröhling; Nicolas Schlegel; Matthias Kroiss
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-23       Impact factor: 5.555

5.  Clinical characteristics and treatment outcomes of parathyroid carcinoma: A retrospective review of 234 cases.

Authors:  Peisong Wang; Shuai Xue; Shuo Wang; Zhi Lv; Xianying Meng; Guimin Wang; Wei Meng; Jia Liu; Guang Chen
Journal:  Oncol Lett       Date:  2017-09-27       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.